학술논문
Homologous recombination repair mutation gene panels (excluding BRCA) are not predictive of maintenance olaparib plus bevacizumab efficacy in the first-line PAOLA-1/ENGOT-ov25 trial
Document Type
Abstract
Author
Pujade-Lauraine, Eric; Brown, Jessica; Barnicle, Alan; Rowe, Phil; Lao-Sirieix, Pierre; Criscione, Steven; du Bois, Andreas; Lorusso, Domenica; Romero, Ignacio; Petru, Edgar; Yoshida, Hiroyuki; Vergote, Ignace; Colombo, Nicoletta; Hietanen, Sakari; Provansal, Magali; Schmalfeldt, Barbara; Pignata, Sandro; Martin-Lorente, Cristina; Berton, Dominique; Runnebaum, Ingo; Ray-Coquard, Isabelle
Source
In Gynecologic Oncology August 2021 162 Supplement 1:S26-S27
Subject
Language
ISSN
0090-8258